51336-47-1

Basic information

• Product Name: AKOS B005891
• Synonyms: AKOS B005891;(4-BROMO-2-FORMYL-PHENOXY)-ACETIC ACID ETHYL ESTER;ART-CHEM-BB B005891;ETHYL (4-BROMO-2-FORMYLPHENOXY)ACETATE;UKRORGSYN-BB BBV-199844;VITAS-BB TBB001420
• CAS NO: 51336-47-1
• Molecular Formula: C₁₁H₁₁BrO₄
• Molecular Weight: 287.11
• Mol File: 51336-47-1.mol
• Article Data: 13

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: AKOS B005891(CAS DataBase Reference)
• NIST Chemistry Reference: AKOS B005891(51336-47-1)
• EPA Substance Registry System: AKOS B005891(51336-47-1)

Safety Data

• Hazardous Substances Data: 51336-47-1(Hazardous Substances Data)

Usage

General Description

AKOS B005891 is a chemical compound with the molecular formula C22H30N6O4S. It has a molecular weight of 466.58 g/mol and is identified as a cetirizine metabolite. Cetirizine is a commonly used antihistamine medication that is used to treat allergy symptoms such as sneezing, itching, and watery eyes. AKOS B005891 is one of the metabolites formed in the body after cetirizine is ingested, and it is important for understanding the pharmacokinetics and metabolism of cetirizine. It is an important chemical for pharmaceutical research and development, particularly in the field of drug metabolism and pharmacokinetics.

Upstream product

• 90-02-8 salicylaldehyde 
• 105-36-2 ethyl bromoacetate 
• 1761-61-1 5-bromosalicyclaldehyde 

Downstream Products

• 188714-86-5 2-Butyl-5-chloro-3-{5-[2-(1-trityl-1H-tetrazol-5-yl)-phenyl]-benzofuran-2-ylmethyl}-3H-imidazole-4-carbaldehyde 
• 188714-87-6 (2-Butyl-5-chloro-3-{5-[2-(1-trityl-1H-tetrazol-5-yl)-phenyl]-benzofuran-2-ylmethyl}-3H-imidazol-4-yl)-methanol 
• 188714-62-7 5-[2-(1-Trityl-1H-tetrazol-5-yl)-phenyl]-benzofuran-2-carboxylic acid ethyl ester 
• 188714-66-1 5-[2-(3-Bromo-2-bromomethyl-benzofuran-5-yl)-phenyl]-1-trityl-1H-tetrazole 
• 188714-64-9 5-[2-(2-Bromomethyl-benzofuran-5-yl)-phenyl]-1-trityl-1H-tetrazole 
• 188714-63-8 {5-[2-(1-Trityl-1H-tetrazol-5-yl)-phenyl]-benzofuran-2-yl}-methanol 
• 188714-65-0 5-[2-(3-Bromo-2-bromomethyl-benzofuran-5-yl)-phenyl]-1H-tetrazole 
• 24589-89-7 2-(4-bromo-2-formylphenoxy)acetic acid 
• 194163-50-3 ethyl [4-bromo-2-(hydroxymethyl)phenoxy]acetate 
• 84102-69-2 5-bromo-benzofuran-2-carboxylic acid ethyl ester 
• 51336-46-0 2,6-Dimethyl-4-(2-ethoxycarbonylmethoxy-5-bromophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester 
• 13923-56-3 ethyl [4-bromo-2-(chloromethyl)phenoxy]Acetate 

Relevant articles and documents

Benzofuran-Based Carboxylic Acids as Carbonic Anhydrase Inhibitors and Antiproliferative Agents against Breast Cancer

Pursuing our effort for developing effective inhibitors of the cancer-related hCA IX isoform, here we describe the synthesis of novel benzofuran-based carboxylic acid derivatives, featuring the benzoic (9a-f) or hippuric (11a,b) acid moieties linked to 2-

Organocatalytic Synthesis of Fused Bicyclic 2,3-Dihydro-1,3,4-oxadiazoles through an Intramolecular Cascade Cyclization

Hydrazone-carboxylic acids undergo intramolecular cyclization in the presence of pivaloyl chloride, iPr2NEt, and catalytic DABCO to form a range of substituted fused tricyclic 2,3-dihydro-1,3,4-oxadiazoles in high yields.

AGENT FOR CONTROLLING FUNCTION OF GPR34 RECEPTOR

The present invention provides a GPR receptor function regulator comprising the compound represented by the formula: [wherein ring A is an optionally substituted isocyclic or heterocyclic ring, P is a bond or spacer, ring D is an optionally substituted monocyclic aromatic ring which may be condensed with a 5-to 7-membered ring, V is a bond or the group represented by the formula -CR14=CR15 - or - N=CR16- (wherein R14, R15 and R16 each represents a hydrogen atom or optionally substituted hydrocarbon group), Q is a bond or spacer, and W is a carboxyl or a group biologically equivalent to a carboxyl] or its salt or a prodrug thereof